Exicure (XCUR) EBT Growth (1y) (2017 - 2026)
Exicure (XCUR) EBT Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-313.33% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
-79.57% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Exicure |
19.38 Mn |
16.77 Mn |
- |
-160.73% |
| Date | Value |
|---|
| Mar 31, 2026 |
-160.73% |
| Dec 31, 2025 |
50.81% |
| Sep 30, 2025 |
-125.02% |
| Jun 30, 2025 |
-336.83% |
| Mar 31, 2025 |
463.09% |
| Dec 31, 2024 |
-382.92% |
| Sep 30, 2024 |
79.39% |
| Jun 30, 2024 |
89.59% |
| Mar 31, 2024 |
81.19% |
| Dec 31, 2023 |
-107.99% |
| Sep 30, 2023 |
-1.86% |
| Jun 30, 2023 |
22.84% |
| Mar 31, 2023 |
47.21% |
| Dec 31, 2022 |
234.58% |
| Sep 30, 2022 |
78.07% |
| Jun 30, 2022 |
47.65% |
| Mar 31, 2022 |
33.09% |
| Dec 31, 2021 |
-8.99% |
| Sep 30, 2021 |
-166.73% |
| Jun 30, 2021 |
-230.99% |
